vorinostat has been researched along with Myotonic Dystrophy in 1 studies
Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).
Myotonic Dystrophy: Neuromuscular disorder characterized by PROGRESSIVE MUSCULAR ATROPHY; MYOTONIA, and various multisystem atrophies. Mild INTELLECTUAL DISABILITY may also occur. Abnormal TRINUCLEOTIDE REPEAT EXPANSION in the 3' UNTRANSLATED REGIONS of DMPK PROTEIN gene is associated with Myotonic Dystrophy 1. DNA REPEAT EXPANSION of zinc finger protein-9 gene intron is associated with Myotonic Dystrophy 2.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Neault, N | 1 |
| Ravel-Chapuis, A | 1 |
| Baird, SD | 1 |
| Lunde, JA | 1 |
| Poirier, M | 1 |
| Staykov, E | 1 |
| Plaza-Diaz, J | 1 |
| Medina, G | 1 |
| AbadÃa-Molina, F | 1 |
| Jasmin, BJ | 1 |
| MacKenzie, AE | 1 |
1 other study available for vorinostat and Myotonic Dystrophy
| Article | Year |
|---|---|
Vorinostat Improves Myotonic Dystrophy Type 1 Splicing Abnormalities in DM1 Muscle Cell Lines and Skeletal Muscle from a DM1 Mouse Model.
Topics: Adult; Alternative Splicing; Animals; Humans; Mice; Muscle Cells; Muscle, Skeletal; Myotonic Dystrop | 2023 |